Henrik Brun, Egidijus Pelanis, Ola Wiig, Javier Armando Luzon, Sigurd Birkeland, Rahul Prasanna Kumar, Åsmund Avdem Fretland, Kathrine Rydén Suther, Bjørn Edwin, Ole Jacob Elle
Henrik Brun, MD, senior consultant at the Department of Paediatric Cardiology, Oslo University Hospital, Rikshospitalet, and postdoctoral fellow at the Intervention Centre, Oslo University Hospital, Rikshospitalet
The author has completed the ICMJE form and declares the following conflict of interest: He is a co-inventor of technology licensed to the company HoloCare AS and owns shares in the company indirectly via Inven2 AS.
Egidijus Pelanis, MD, researcher at the Intervention Centre, Oslo University Hospital, Rikshospitalet, and PhD candidate at the Institute of Clinical Medicine, University of Oslo.
The author has completed the ICMJE form and declares the following conflict of interest: He is a co-inventor of technology licensed to the company HoloCare AS and owns shares in the company indirectly via Inven2 AS.
Ola Wiig, MD, senior consultant at the Division of Orthopaedic Surgery, Oslo University Hospital, Rikshospitalet.
The author has completed the ICMJE form and declares the following conflict of interest: He is a co-inventor of technology licensed to the company HoloCare AS and owns shares in the company indirectly via Inven2 AS.
Javier Armando Luzon, MD, specialty registrar at the Department of Gastrointestinal Surgery, Akershus University Hospital, and clinical PhD candidate and lecturer at the Institute of Clinical Medicine, University of Oslo.
The author has completed the ICMJE form and declares the following conflict of interest: He is a co-inventor of technology licensed to the company HoloCare AS and owns shares in the company indirectly via Inven2 AS.
Rahul Prasanna Kumar, engineer and postdoctoral fellow at the Intervention Centre, Oslo University Hospital, Rikshospitalet
The author has completed the ICMJE form and declares the following conflict of interest: He is a co-inventor of technology licensed to the company HoloCare AS and owns shares in the company indirectly via Inven2 AS.
Åsmund Avdem Fretland, MD, senior consultant at the Intervention Centre and Unit for Liver and Pancreatic Surgery, Oslo University Hospital, Rikshospitalet.
The author has completed the ICMJE form and declares no conflicts of interest.
Kathrine Rydén Suther, MD, senior consultant at Section of Paediatric Radiology, Department of Radiology, Rikshospitalet, Division of Radiology and Nuclear Medicine, Oslo University Hospital.
The author has completed the ICMJE form and declares no conflicts of interest.
Bjørn Edwin, MD, senior consultant at the Intervention Centre and Unit for Liver and Pancreatic Surgery, Oslo University Hospital, Rikshospitalet, and professor at the Institute of Clinical Medicine, University of Oslo.
The author has completed the ICMJE form and declares the following conflict of interest: He is a co-inventor of technology licensed to the company HoloCare AS and owns shares in the company indirectly via Inven2 AS.
Ole Jacob Elle, head of Section for Medical Cybernetics and Image Processing, the Intervention Centre, Oslo University Hospital, and professor at the Department of Informatics, University of Oslo.
The author has completed the ICMJE form and declares the following conflict of interest: He is a co-inventor of technology licensed to the company HoloCare AS and owns shares in the company indirectly via Inven2 AS.
If you do not see the PDF file or want to save the file, you can right-click on the PDF icon. Select «Save target / file as ...» and then retrieve the PDF file in, for example, Acrobat Reader.